APLLTD - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.4
| Stock Code | APLLTD | Market Cap | 15,174 Cr. | Current Price | 771 ₹ | High / Low | 1,108 ₹ |
| Stock P/E | 29.9 | Book Value | 267 ₹ | Dividend Yield | 1.43 % | ROCE | 11.3 % |
| ROE | 9.68 % | Face Value | 2.00 ₹ | DMA 50 | 741 ₹ | DMA 200 | 826 ₹ |
| Chg in FII Hold | 0.03 % | Chg in DII Hold | 0.00 % | PAT Qtr | 149 Cr. | PAT Prev Qtr | 179 Cr. |
| RSI | 59.7 | MACD | 15.2 | Volume | 2,45,612 | Avg Vol 1Wk | 1,68,559 |
| Low price | 635 ₹ | High price | 1,108 ₹ | PEG Ratio | -9.06 | Debt to equity | 0.27 |
| 52w Index | 28.7 % | Qtr Profit Var | 74.0 % | EPS | 24.0 ₹ | Industry PE | 30.9 |
📊 Analysis: APLLTD shows moderate fundamentals with ROCE at 11.3% and ROE at 9.68%, which are below ideal levels for strong long-term compounding. The P/E ratio of 29.9 is close to the industry average of 30.9, suggesting fair valuation. EPS of 24.0 ₹ provides earnings visibility, and dividend yield of 1.43% adds modest income support. However, the PEG ratio of -9.06 indicates weak growth prospects relative to valuation. Debt-to-equity at 0.27 is manageable, but quarterly PAT declined (149 Cr vs 179 Cr), reflecting earnings pressure.
💰 Entry Price Zone: Ideal accumulation range is 740 ₹ – 760 ₹, near the 50 DMA (741 ₹), offering a safer entry below current levels.
📈 Exit Strategy / Holding Period: For existing holders, maintain a medium-term horizon (2–3 years) given fair valuation and modest dividend yield. Consider partial profit booking near 850 ₹ – 900 ₹ resistance levels. Long-term holding is not recommended unless ROE/ROCE improve significantly and earnings growth stabilizes.
✅ Positive
- Dividend yield of 1.43% provides modest income support.
- EPS of 24.0 ₹ ensures earnings visibility.
- Debt-to-equity ratio of 0.27 is manageable.
- FII holdings increased slightly (+0.03%), signaling foreign investor confidence.
⚠️ Limitation
- Weak ROCE (11.3%) and ROE (9.68%) limit efficiency.
- PEG ratio of -9.06 indicates poor growth prospects.
- Quarterly PAT declined (149 Cr vs 179 Cr).
- DII holdings remained flat (-0.00%), showing limited domestic support.
📉 Company Negative News
- No major negative news reported, but declining quarterly profits are a concern.
📈 Company Positive News
- Dividend yield supports investor returns.
- Stable valuation close to industry average.
🏭 Industry
- Industry P/E at 30.9 suggests moderate sector valuation.
- Pharmaceutical sector benefits from consistent demand and long-term growth opportunities.
🔎 Conclusion
APLLTD is moderately attractive but faces challenges with weak profitability metrics and declining earnings. Entry near 740–760 ₹ provides better margin of safety. Hold for 2–3 years to benefit from dividend yield and potential recovery, but monitor quarterly performance closely. Partial exits near 850–900 ₹ are advisable unless ROE and ROCE improve significantly.